Accenture and Roche collaborate to enhance digital healthcare for cancer patients
Dec 21, 2017
Data Integration Services Crucial to Decision Support in Oncology
NEW YORK; Dec. 20, 2017 – Accenture (NYSE: ACN) today announced a collaborative services agreement with Roche. Under the terms of this exclusive multi-year agreement, Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.
A tumor board is a meeting in which multi-disciplinary healthcare teams review and discuss individual cancer patient cases and available treatment options. The NAVIFY Tumor Board solution streamlines and standardizes the tumor board workflow process by aggregating relevant patient data from disparate IT systems into a software solution that fosters efficient team collaboration, reduces errors, and gives the care team more time to evaluate individual patient cases.
The data integration capabilities Accenture provides will allow Roche to integrate patient data between hospitals and the NAVIFY Tumor Board solution to support clinicians in arriving at the best possible treatment decisions for their patients. The NAVIFY Tumor Board solution is built on a secure cloud platform.
“Our collaboration with Accenture is another exciting step forward in providing personalized healthcare solutions to patients,” said Tim M. Jaeger, Global Head of Diagnostics Information Solutions for Roche. “Tumor board coordination is labor intensive and time consuming for healthcare providers. Accenture’s global scale, deep digital expertise, and innovation capabilities in the healthcare and life sciences industries allows Roche to continue our focus on delivering workflow and decision support solutions to customers and improving patient outcomes.”
Andrea Brückner, who leads Accenture’s Life Sciences practice in Europe, said:
“With Roche, we continue to provide meaningful impact on patients’ lives by combining new science with leading-edge technology to revolutionize patient care. By providing data integration services to the NAVIFY Tumor Board solution, we aim to ensure that all available data is used to accelerate and optimize treatment decisions for cancer patients.”
As shared in an October 2017 announcement, the NAVIFY Tumor Board solution fundamentally changes the way tumor board meetings are organized and conducted with the goal of fostering collaboration on patient treatment decisions. It is currently available in the US, UK, Germany, Spain, Sweden, Switzerland, and the Netherlands.
Sign up to receive TelecomTV's top news and videos, plus exclusive subscriber-only content direct to your inbox.